CA Stock MarketDetailed Quotes
AWKN Awakn Life Sciences Corp
- 0.095
- 0.0000.00%
15min DelayMarket Closed Dec 6 14:55 ET
3.96MMarket Cap-1.19P/E (TTM)
0.000High0.000Low0Volume0.000Open0.095Pre Close0.00Turnover0.23052wk High0.00%Turnover Ratio41.66MShares0.06052wk Low-0.08EPS TTM3.32MFloat Cap0.230Historical HighLossP/E (Static)34.94MShs Float0.060Historical Low-0.18EPS LYR0.00%Amplitude--Dividend TTM-2.50P/B1Lot Size--Div YieldTTM
Awakn Life Sciences Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | (Q3)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -99.50%3.43K | 66.23%-501.25K | 58.02%-1.61M | -27.91%3.33M | 30.33%-4.14M | 228.05%682.16K | 25.27%-1.48M | 55.21%-3.85M | 225.35%4.62M | -44.94%-5.94M |
| Net income from continuing operations | -1,177.31%-360.99K | 67.57%-544.82K | 25.94%-3.67M | -52.63%2.13M | 33.25%-4.09M | 94.56%-28.26K | 40.01%-1.68M | 69.91%-4.96M | 207.53%4.49M | 44.37%-6.13M |
| Operating gains losses | ---- | ---- | 623.76%46.29K | 1,144.70%403.22K | ---9.38K | ---- | ---- | -100.17%-8.84K | ---38.6K | ---- |
| Depreciation and amortization | 28.06%4.66K | 32.79%4.76K | 30.18%18.29K | 46.95%4.78K | 75.03%6.3K | 102.75%3.64K | -97.42%3.59K | -92.25%14.05K | -96.51%3.25K | -95.52%3.6K |
| Remuneration paid in stock | -94.16%33.44K | -53.60%36.89K | 29.52%813.72K | -56.12%93.71K | -8.27%67.93K | 303.53%572.58K | -60.00%79.51K | -42.38%628.23K | -32.15%213.55K | -82.97%74.05K |
| Other non cashItems | ---- | ---- | ---5 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -32.27%326.32K | -98.30%1.91K | 146.49%1.18M | 1,391.77%698.41K | -245.70%-114.47K | 476.67%481.77K | -80.62%112.67K | -11.08%478.07K | 58.00%-54.07K | -85.72%78.57K |
| -Change in receivables | 98.89%-1.5K | 61.18%-13.78K | 7,670.78%78.72K | 156.02%322.74K | -155.34%-74.15K | -169.27%-134.38K | 23.02%-35.49K | 101.21%1.01K | 119.89%126.06K | 77.32%-29.04K |
| -Change in prepaid assets | -191.37%-91.39K | -39.67%47.74K | 340.90%195.84K | -34.70%72.48K | 68.99%-55.79K | 602.54%100.02K | -20.16%79.13K | 110.78%44.42K | 48.66%110.99K | 57.16%-179.93K |
| -Change in payables and accrued expense | -71.96%145.19K | -174.40%-34.27K | 107.19%896.4K | 209.23%318K | -94.95%14.52K | 631.58%517.82K | -91.37%46.07K | -57.72%432.64K | -7.34%-291.12K | -73.82%287.53K |
| -Change in other working capital | 16,294.74%274.02K | -90.31%2.22K | --7.42K | ---14.81K | --965 | ---1.69K | 543.44%22.96K | ---- | ---- | ---- |
| Cash from discontinued investing activities | 0 | 0 | 102.17%41.89K | -432.86K | -391.94K | -1.93M | ||||
| Operating cash flow | -98.63%3.43K | 73.29%-501.25K | 58.02%-1.61M | -37.19%4.11M | 47.93%-4.1M | 146.80%249.3K | 5.54%-1.88M | 55.21%-3.85M | 277.71%6.55M | -91.97%-7.87M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | -28.91%60.74K | 0 | 0 | ||||
| Net business purchase and sale | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
| Cash from discontinued investing activities | 0 | 0 | 0 | -10.87K | -70.27K | -6.49K | ||||
| Investing cash flow | --0 | --0 | --0 | -78.81%20.41K | --0 | 1,241.79%49.86K | 17.75%-70.27K | --0 | 117.41%96.29K | 99.38%-6.49K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -29.92%590.94K | -81.90%195.65K | -56.25%2.66M | -101.93%-33K | -40.58%764.72K | 1,238.40%843.2K | -64.13%1.08M | -47.21%6.07M | 646.84%1.71M | -82.63%1.29M |
| Net common stock issuance | -29.92%590.94K | -81.90%195.65K | -55.53%2.66M | -101.84%-33K | -30.47%764.72K | --843.2K | -64.86%1.08M | -20.24%5.97M | --1.8M | -85.31%1.1M |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -70.15%99.17K | -131.03%-87.96K | ---- |
| Cash from discontinued financing activities | 0 | 0 | 0 | -88.08K | -111.89K | 503.77K | ||||
| Financing cash flow | -21.74%590.94K | -79.81%195.65K | -56.25%2.66M | -87.63%166.97K | -57.30%764.72K | 1,011.81%755.13K | -67.84%969.2K | -47.21%6.07M | 490.32%1.35M | -75.83%1.79M |
| Net cash flow | ||||||||||
| Beginning cash position | -69.02%120.73K | -26.06%407.3K | -66.06%550.87K | -34.75%738.97K | -10.80%429.78K | -86.18%389.7K | -66.06%550.87K | 343.42%1.62M | -79.95%1.13M | -85.61%481.83K |
| Current changes in cash | 963.22%594.36K | -309.69%-305.6K | 105.14%54.22K | 76.56%-132.41K | -89.85%109.75K | 97.26%-68.85K | -84.52%145.74K | -185.81%-1.06M | 85.91%-564.79K | -52.18%1.08M |
| Effect of exchange rate changes | -100.81%-2.39K | 106.20%19.02K | 20.42%-13.48K | 11.74%-14.94K | 103.51%15.12K | 66.46%293.26K | -220.76%-306.91K | -162.14%-16.93K | -2.07%-16.93K | -1,239.01%-430.31K |
| End cash Position | 65.83%712.71K | -69.02%120.73K | 7.40%591.62K | 7.40%591.62K | -34.75%738.97K | -10.80%429.78K | -86.18%389.7K | -66.06%550.87K | -66.06%550.87K | -79.95%1.13M |
| Free cash from | -98.63%3.43K | 73.29%-501.25K | 58.02%-1.61M | -37.19%4.11M | 47.93%-4.1M | 155.74%249.3K | 9.44%-1.88M | 62.64%-3.85M | 254.51%6.55M | -52.27%-7.87M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data